Search research articles
Contact Us
Filters
Showing results (11-20 of 41) with videos related to
Page
of 5
Sort By:
Dermatologica
|
January 1, 1984
Reduction of the in vivo virulence of Candida albicans by pretreatment with subinhibitory azole concentrations in vitro
M Plempel, D Berg
Arzneimittel-Forschung
|
August 1, 1972
[Experimental study of the antimycotic effect of clotrimazole in vitro and in vivo when administered locally]
M Plempel, K Bartmann
Mykosen
|
December 1, 1983
[Microbiological determination of the oral antifungal agent Bay N 7133 and ketoconazole in cervical and vaginal secretion of patients]
W Nusch, M Plempel
Sabouraudia
|
March 1, 1978
Kidney homogenate, a test medium to determine the inhibitory effect of antimycotics on yeasts
I Haller, M Plempel
Chemotherapy
|
January 1, 1982
Vaginal secretion levels after 6 days, 3 days and 1 day of treatment with 100, 200 and 500 mg vaginal tablets of clotrimazole and their therapeutic efficacy
W Mendling, M Plempel
Dermatologica
|
January 1, 1984
Bifonazole, a biochemist's view
D Berg, M Plempel
Current Medical Research and Opinion
|
January 1, 1977
Experimental in vitro and in vivo comparison of modern antimycotics
I Haller, M Plempel
Deutsche Medizinische Wochenschrift (1946)
|
August 16, 1974
[The clinical picture of coccidioidomycosis, as experienced during a laboratory infection (author's transl)]
T Wegmann, M Plempel
The Journal of Antimicrobial Chemotherapy
|
September 1, 1984
Pharmacokinetics of the oral triazole antimycotic vibunazole in animals
W Ritter, M Plempel
Journal of Enzyme Inhibition
|
January 1, 1989
Inhibitors of fungal sterol synthesis: squalene-epoxidation and C-14-demethylation
D Berg, M Plempel
Page
of 5
Search research articles
Search
Showing results (11-20 of 41) with videos related to
Sort By:
Page
of 5
Dermatologica
|
January 1, 1984
Reduction of the in vivo virulence of Candida albicans by pretreatment with subinhibitory azole concentrations in vitro
M Plempel, D Berg
Arzneimittel-Forschung
|
August 1, 1972
[Experimental study of the antimycotic effect of clotrimazole in vitro and in vivo when administered locally]
M Plempel, K Bartmann
Mykosen
|
December 1, 1983
[Microbiological determination of the oral antifungal agent Bay N 7133 and ketoconazole in cervical and vaginal secretion of patients]
W Nusch, M Plempel
Sabouraudia
|
March 1, 1978
Kidney homogenate, a test medium to determine the inhibitory effect of antimycotics on yeasts
I Haller, M Plempel
Chemotherapy
|
January 1, 1982
Vaginal secretion levels after 6 days, 3 days and 1 day of treatment with 100, 200 and 500 mg vaginal tablets of clotrimazole and their therapeutic efficacy
W Mendling, M Plempel
Dermatologica
|
January 1, 1984
Bifonazole, a biochemist's view
D Berg, M Plempel
Current Medical Research and Opinion
|
January 1, 1977
Experimental in vitro and in vivo comparison of modern antimycotics
I Haller, M Plempel
Deutsche Medizinische Wochenschrift (1946)
|
August 16, 1974
[The clinical picture of coccidioidomycosis, as experienced during a laboratory infection (author's transl)]
T Wegmann, M Plempel
The Journal of Antimicrobial Chemotherapy
|
September 1, 1984
Pharmacokinetics of the oral triazole antimycotic vibunazole in animals
W Ritter, M Plempel
Journal of Enzyme Inhibition
|
January 1, 1989
Inhibitors of fungal sterol synthesis: squalene-epoxidation and C-14-demethylation
D Berg, M Plempel
Page
of 5